Top Markets
#1 Black Phoenix Black Phoenix +733.92%
#2 Biconomy Biconomy +28.18%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.97%
#4 TENDIES TENDIES +21.95%
#5 MetaDAO MetaDAO +19.52%
#6 THORChain THORChain +19.00%
#7 Wrapped STX (Velar) Wrapped STX (Velar) +17.65%
#8 Moolah Moolah +16.24%
#9 Pons Pons +13.92%
#10 THORChain Yield THORChain Yield +13.85%
Coin of the day
Black Phoenix Black Phoenix
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

300255
Clasificación en acciones #4864
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. operates within China,... Hebei Changshan Biochemical Pharmaceutical Co., Ltd. operates within China, focusing on the entire lifecycle of heparin-based pharmaceuticals – from their initial research and development to manufacturing and sales. Their products are primarily utilized for the treatment of cardiovascular and cerebrovascular diseases. The company offers a broad range of heparin compounds, including crude heparin sodium and refined heparin sodium raw materials. Their portfolio also features a variety of injectable heparin preparations, such as standard heparin sodium injections. Furthermore, they produce both the raw materials and finished injectable forms for several low molecular weight heparins, specifically low molecular weight heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium. Established in the year 2000, Hebei Changshan Biochemical Pharmaceutical Co., Ltd. is headquartered in Shijiazhuang, China.
Precio por acción
$3.50
Capitalización bursátil
$3.22B
Cambio (1 día)
1.17%
Cambio (1 año)
-50.77%
País
CN
Comercio Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255)

Categoría

Healthcare
Ingresos de Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255)
Ingresos en Aug 2026 TTM: 0
Según los últimos informes financieros de Hebei Changshan Biochemical Pharmaceutical Co., Ltd., los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Hebei Changshan Biochemical Pharmaceutical Co., Ltd. desde 2026 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
Not enough data for the provided dates.
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH